Cargando…

The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date

Glucagon-like peptide 1 receptor agonists (GLP1-RA) are prominent agents in the therapeutics of type 2 diabetes mellitus due to their exemplary efficacy in both preprandial and postprandial glycemia, their safety, low risk of hypoglycemia, their multilevel pathophysiological superiority, weight loss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antza, Christina, Nirantharakumar, Krishnarajah, Doundoulakis, Ioannis, Tahrani, Abd A, Toulis, Konstantinos A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709822/ https://www.ncbi.nlm.nih.gov/pubmed/31686781 http://dx.doi.org/10.2147/DDDT.S166765

Ejemplares similares

The links between sleep duration, obesity and type 2 diabetes mellitus
por: Antza, Christina, et al.
Publicado: (2021)

Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis
por: Kostopoulos, Georgios, et al.
Publicado: (2021)

Sleep behaviours and associated habits and the progression of pre-diabetes to type 2 diabetes mellitus in adults: A systematic review and meta-analysis
por: Mostafa, Samiul A, et al.
Publicado: (2022)

The Depiction of Hypertension in Heart Imaging Examinations: An Up-to-Date Review of the Evidence
por: Vasileiadis, Konstantinos, et al.
Publicado: (2023)

Sodium‐glucose cotransporter‐2 inhibitors and the risk of gout in patients with type 2 diabetes mellitus: A propensity‐score‐matched, new‐user design study with an active comparator using the IQVIA Medical Research Data UK database
por: Subramanian, Anuradhaa, et al.
Publicado: (2022)

Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study
por: Kumarendran, Balachandran, et al.
Publicado: (2021)

Pubertal timing in boys and girls born to mothers with gestational diabetes mellitus: a systematic review
por: Subramanian, Anuradhaa, et al.
Publicado: (2020)

Clinically meaningful and lasting HbA(1c) improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis
por: Nirantharakumar, Krishnarajah, et al.
Publicado: (2018)

Long term miscarriage-related hypertension and diabetes mellitus. Evidence from a United Kingdom population-based cohort study
por: Okoth, Kelvin, et al.
Publicado: (2022)

Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study
por: Kumarendran, Balachandran, et al.
Publicado: (2019)

Disease burden of diabetes, diabetic retinopathy and their future projections in the UK: cross-sectional analyses of a primary care database
por: Haider, Sajjad, et al.
Publicado: (2021)

American, European and international hypertension guidelines: Time to shake hands?
por: Antza, Christina, et al.
Publicado: (2020)

Serum testosterone, sex hormone‐binding globulin and sex‐specific risk of incident type 2 diabetes in a retrospective primary care cohort
por: O’Reilly, Michael W., et al.
Publicado: (2018)

GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
por: Yu, Ji Hee, et al.
Publicado: (2022)

Mobile Clinical Decision Support System for the Management of Diabetic Patients With Kidney Complications in UK Primary Care Settings: Mixed Methods Feasibility Study
por: Alhodaib, Hala Ibrahim, et al.
Publicado: (2020)

Evidence for Cardiorenal Protection with SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Patients with Diabetic Kidney Disease
por: Georgianos, Panagiotis I., et al.
Publicado: (2022)

Data extraction for epidemiological research (DExtER): a novel tool for automated clinical epidemiology studies
por: Gokhale, Krishna Margadhamane, et al.
Publicado: (2020)

The clinical profile and associated mortality in people with and without diabetes with Coronavirus disease 2019 on admission to acute hospital services
por: Gokhale, Krishna, et al.
Publicado: (2021)

Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study
por: Daly, Barbara, et al.
Publicado: (2018)

Post-bariatric surgery nutritional follow-up in primary care: a population-based cohort study
por: Parretti, Helen M, et al.
Publicado: (2021)

Correction: Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study
por: Daly, Barbara, et al.
Publicado: (2019)

Evaluation of subclinical cardiac damage in biopsy-proven nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Oikonomidou, Artemis Christina, et al.
Publicado: (2021)

Role and development of GLP-1 receptor agonists in the management of diabetes
por: Chia, Chee W, et al.
Publicado: (2009)

Effects of GLP-1 receptor agonists on neurological complications of diabetes
por: García-Casares, Natalia, et al.
Publicado: (2023)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy
por: Oezer, Kuebra, et al.
Publicado: (2023)

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
por: Nauck, Michael A., et al.
Publicado: (2020)

Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study
por: Wang, Zhaonan, et al.
Publicado: (2022)

The Cardiovascular Effects of GLP-1 Receptor Agonists
por: Okerson, Theodore, et al.
Publicado: (2012)

GLP-1 Receptor Agonists and Kidney Protection
por: Greco, Eulalia Valentina, et al.
Publicado: (2019)

Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study
por: Dafoulas, George E., et al.
Publicado: (2016)

Discriminatory performance of adiponectin and leptin in the identification of impaired glucose tolerance: The Guangzhou Biobank Cohort Study - Cardiovascular Disease Subcohort
por: Toulis, Konstantinos A., et al.
Publicado: (2018)

Risk of incident obstructive sleep apnoea in patients with type 1 diabetes: a population-based retrospective cohort study
por: Alshehri, Ziyad, et al.
Publicado: (2022)

Treatment of Type 2 Diabetes With GLP-1 Receptor Agonists Among Patients With CKD
por: Østergaard, Jakob A., et al.
Publicado: (2022)

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
por: Ma, Xiaoxuan, et al.
Publicado: (2021)

GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
por: del Olmo-Garcia, María Isabel, et al.
Publicado: (2018)

The impact of sleep disorders on microvascular complications in patients with type 2 diabetes (SLEEP T2D): the protocol of a cohort study and feasibility randomised control trial
por: Antza, Christina, et al.
Publicado: (2021)

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist
por: Kawai, Takahiro, et al.
Publicado: (2020)

Ramadan is not associated with increased infection risk in Pakistani and Bangladeshi populations: Findings from controlled interrupted time series analysis of UK primary care data
por: Almulhem, Munerah, et al.
Publicado: (2022)

Basal Insulin Use With GLP-1 Receptor Agonists
por: Anderson, Sarah L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_97sbk6qr9kgphothbb6pvth804